Tech Company Financing Transactions
Sialix Funding Round
Beacon Angels, Boston Harbor Angels and Desert Angels invested in a $1.2 million funding round for Sialix. The funding round was announced on 2/5/2014.
Transaction Overview
Company Name
Announced On
2/5/2014
Transaction Type
Venture Equity
Amount
$1,200,000
Round
Undisclosed
Investors
Proceeds Purpose
We are very excited about the work they are doing in developing therapeutic antibodies targeting tumor associated glycans to address the multi-faceted challenges of cancer.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
90 Bridge St. 100
Newton, MA 02458
USA
Newton, MA 02458
USA
Phone
Website
Email Address
Overview
Sialix is developing products based on new biological discoveries of non-human sialic acids, their dietary role and inflammatory consequences, and their potential impact on cancer, cardiovascular, and other inflammatory-mediated diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Brad Curley
Chief Executive Officer
Jeffrey Behrens
VP - R & D
Daniel Dransfield
Browse more venture capital transactions:
Prev: 2/5/2014: DataXu venture capital transaction
Next: 2/5/2014: FarFaria venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs